Liver Sinusoidal Endothelial Cells (LSECs) in Non-alcoholic Fatty Liver Disease (NAFLD) demonstrate compensatory transcriptional changes

被引：0
|
作者：
McMahan, Rachel [1 ]
Giugliano, Silvia [1 ]
Porsche, Cara [1 ]
Golden-Mason, Lucy [1 ]
Rosen, Hugo R. [2 ,3 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] Univ Colorado, Integrated Program Immunol, Denver, CO 80202 USA
[3] Natl Jewish Hosp, Denver, CO USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
523
引用
收藏
页码：459A / 459A
页数：1
相关论文
共 50 条
  • [41] Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
    Koralegedara, Iresha Sandamali
    Warnasekara, Janith Niwanthaka
    Rathnayake, Ashani
    Dayaratne, Korale Gedara
    Agampodi, Suneth Buddhika
    BMJ OPEN GASTROENTEROLOGY, 2022, 9 (01):
  • [42] Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)
    Choudhary, Narendra Singh
    Duseja, Ajay
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [43] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
  • [44] Non-alcoholic fatty liver disease (NAFLD) recurrence after liver transplant (OLT) for non-alcoholic steatohepatitis(NASH)
    Kawamura, Norio
    Nazzal, Mustafa
    El-Gazzaz, Galal
    Spaggiari, Mario
    Fujiki, Masato
    Diago, Teresa
    Aucejo, Federico N.
    Hashimoto, Koji
    Quintini, Cristiano
    Winans, Charles
    Eghtesad, Bijan
    Miller, Charles M.
    Fung, John J.
    Alkhouri, Naim
    Kelly, Dympna
    HEPATOLOGY, 2014, 60 : 617A - 617A
  • [45] MicroRNAs in the Liver and Visceral Adipose Tissue in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Soronen, Jarkko
    Perttila, Julia
    Yki-Jarvinen, Hannele
    Olk-Konen, Vesa
    DIABETES, 2012, 61 : A43 - A44
  • [46] Leptin: Is it a possible specific liver drug for non-alcoholic fatty liver disease (NAFLD)?
    Xin, Yong-Ning
    Xuan, Shi-Ying
    Guan, Hua-Shi
    MEDICAL HYPOTHESES, 2008, 71 (03) : 462 - 463
  • [47] Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
    Armstrong, Matthew J.
    Haydon, Geoffrey
    Syn, Wing-Kin
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 138 - 142
  • [48] In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kanuri, Giridhar
    Bergheim, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 11963 - 11980
  • [49] Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
    Cole, Banumathi K.
    Feaver, Ryan E.
    Wamhoff, Brian R.
    Dash, Ajit
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (02) : 193 - 205
  • [50] Non-alcoholic fatty liver disease (NAFLD) among underweight adults
    Fahim, Shah Mohammad
    Chowdhury, Muhammad Abdul Baker
    Alam, Shahinul
    CLINICAL NUTRITION ESPEN, 2020, 38 : 80 - 85
12345